The Patent Finder
US

Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS

US 9,567,400 In force
OverviewFamilyAssignmentsSources & methods

Term ends Jul 25, 2028 · High confidence

Filed Jan 27, 2015 as application 14/606,239 · Granted Feb 14, 2017
Base term, 20 years from filing
Today
20 years from filing
2008 2028
Clock starts
Jul 25, 2008
Term ends
Jul 25, 2028
Granted
Feb 14, 2017
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 8,974,791, to Jul 25, 2028. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 25, 2008, when application 12/179,806, the earliest non-provisional in its chain, was filed (this one was filed Jan 27, 2015)Jul 25, 2028High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 8,974,791)resolves to Jul 25, 2028, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 25, 2028High confidence

This family

US 8,974,791In force
Jul 2028
Jul 2028
US 9,567,400this patent
Jul 2028
Jul 2028
US 10,202,467In force
Jul 2028
Jul 2028
US 11,512,145In force
Jul 2028
Jul 2028
Application 18/048,000Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 5, 2015
Reel 35842, frame 374
Pardridge, William M.; Boado, Ruben J.Armagen Technologies, Inc.Assignment of Assignor's Interest
Feb 2, 2018
Reel 44815, frame 135
Armagen, Inc.Oxford Finance LLC, as Collateral Agent and LenderSecurity Interest
Nov 18, 2019
Reel 51042, frame 528
Oxford Finance LLCJCR Pharmaceuticals Co., Ltd.Assignment of Assignor's Interest
Apr 11, 2020
Reel 52373, frame 585
JCR Pharmaceuticals Co., Ltd.Armagen, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited